INTERMEDIATE COMPOUND FOR SYNTHESIZING PHARMACEUTICAL AGENT AND PRODUCTION METHOD THEREOF
申请人:OKUYAMA Masahiro
公开号:US20110251385A1
公开(公告)日:2011-10-13
The present invention relates to a production method of an optically active morpholine compound represented by the formula 10, which includes the following steps:
wherein each symbol is as defined in the specification.
The present invention also relates to a production method of an compound represented by the formula 55, which includes the following steps:
wherein each symbol is as defined in the specification.
According to the production method of the present invention, an optically active 2-aryl-substituted morpholine compound and 3-oxo-3-(pyrimidin-4-yl)propionate, which are important as starting materials for synthesizing 2-(2-arylmorpholin-4-yl)-1-methyl-1H-[4,4′]bipyrimidinyl-6-one having a tau protein kinase 1 inhibitory activity and useful as a therapeutic drug for Alzheimer's disease and the like, can be produced in a high yield by an industrially advantageous method.
本发明涉及一种光学活性吗啉化合物的生产方法,其由公式10表示,包括以下步骤:其中每个符号如规范中所定义。本发明还涉及一种由公式55表示的化合物的生产方法,其包括以下步骤:其中每个符号如规范中所定义。根据本发明的生产方法,可以通过一种工业上有利的方法高产地生产重要的起始材料,即光学活性2-芳基取代吗啉化合物和3-氧代-3-(嘧啶-4-基)丙酸酯,用于合成具有tau蛋白激酶1抑制活性的2-(2-芳基吗啉-4-基)-1-甲基-1H-[4,4′]联吡啶基-6-酮,该化合物对阿尔茨海默病等有用作用的治疗药物。